According to a new study conducted by the American Chemical Society, microbes present in our gut influence the onset of diseases throughout the body. The study has found a way to use chemical compounds to prevent the growth of specific microbes in the digestive system linked to diseases without causing any harm to other organisms.
According to some recent studies, changes in these intestinal florae or microbiome may play a role in giving rise to certain diseases such as allergies, asthma, cancer, diabetes, obesity, autism and multiple sclerosis.
Antibiotic scan help control the microbiome as it can clear some of the organisms that contribute to a healthy microbiome, but microbes that replace the microbiome can sometimes cause more harm than good.
To resolve the issues, the team has also examined using probiotics and fecal transplant. Some researchers investigated by looking at the microbiome to improve health. Researchers to help fill in the gap used chemical compounds to target and interrupt metabolic processes of members of Bacteroides genus.
Bacteroides genus is bacteria found in the gut and is linked to the onset of Type 1 diabetes.
The study has found that acarbose (a drug used to treat diabetes) significantly interrupted the activity of a group of proteins involved in Starch Utilization System.
The team has found that as a result, the bacteria cannot grow and acarbose was specific. It had similar effects on other Bacteroides bacteria, but little or no effect on other types of microbes.
The findings were published in the journal of ACS Chemical Biology.